haloperidol has been researched along with cyclohexanol in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (20.00) | 18.2507 |
2000's | 7 (46.67) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almirall, M; Berrozpe, JD; Escribano, E; Montaña, J; Obach, R | 1 |
Benazzi, F | 1 |
Hata, G; Toda, T; Uemura, M; Weine, FS | 1 |
Chan, KW; Lim, HK; Scatina, JA; Sisenwine, S | 1 |
Andersson, M; Fuxe, K; Strömberg, I; Terasmaa, A | 1 |
Beljean, M; Cutroneo, P; Luu, RP; Siouffi, AM | 1 |
Archambaud, F; Buhl, C; Chouinard, G; Corruble, E; Hardy, P; Prigent, A; Schuster, JP | 1 |
Akhter, N; Kinuya, S; Mori, H; Nakajima, K; Ogawa, K; Shiba, K | 1 |
Elgorashi, AS; Heard, CM; Niazy, EM; Noureldin, OH; Pugh, WJ | 1 |
Dhir, A; Kulkarni, SK | 1 |
Ding, ZB; Lu, L; Shi, HS; Wang, SJ; Wu, P; Zhu, WL | 1 |
Ardashov, OV; Il'ina, IV; Karpova, EV; Korchagina, DV; Morozova, EA; Pavlova, AV; Salakhutdinov, NF; Tolstikova, TG; Volcho, KP | 1 |
Bayram, E; Bayram, M; Dalat, D | 1 |
Alzraikat, H; Hassouneh, L; Taha, NA | 1 |
Alfredo, E; Amaral, MC; Miranda, CE; Palhais, M; Rached-Junior, FJ; Silva-Sousa, YT; Sousa-Neto, MD | 1 |
15 other study(ies) available for haloperidol and cyclohexanol
Article | Year |
---|---|
Effect of d-limonene, alpha-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol.
Topics: Antipsychotic Agents; Bicyclic Monoterpenes; Chlorpromazine; Chromatography, High Pressure Liquid; Cyclohexanols; Cyclohexenes; Diffusion; Eucalyptol; Female; Haloperidol; Humans; In Vitro Techniques; Limonene; Menthol; Middle Aged; Monoterpenes; Pharmaceutic Aids; Skin Absorption; Solubility; Spectrophotometry, Ultraviolet; Stimulation, Chemical; Terpenes | 1996 |
Urinary retention with venlafaxine-haloperidol combination.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Drug Therapy, Combination; Haloperidol; Humans; Male; Urinary Retention; Venlafaxine Hydrochloride | 1997 |
Effectiveness of eucalyptol and d-limonene as gutta-percha solvents.
Topics: Chloroform; Cyclohexanols; Cyclohexenes; Dental Pulp Cavity; Epoxy Resins; Eucalyptol; Gutta-Percha; Humans; Limonene; Materials Testing; Menthol; Models, Structural; Monoterpenes; Root Canal Obturation; Solubility; Solvents; Terpenes; Time Factors | 1997 |
Simultaneous screen for microsomal stability and metabolite profile by direct injection turbulent-laminar flow LC-LC and automated tandem mass spectrometry.
Topics: Animals; Chromatography, Liquid; Cyclohexanols; Drug Evaluation, Preclinical; Haloperidol; Microsomes, Liver; Pharmaceutical Preparations; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2001 |
Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Topics: Analgesics; Animals; Basal Ganglia; Binding, Competitive; Cyclohexanols; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Up-Regulation | 2005 |
Optimization of the separation of some psychotropic drugs and their respective metabolites by liquid chromatography.
Topics: Acetonitriles; Buffers; Chromatography, High Pressure Liquid; Cyclohexanols; Haloperidol; Hydrogen-Ion Concentration; Methanol; Models, Theoretical; Psychotropic Drugs; Risperidone; Solvents; Time Factors; Venlafaxine Hydrochloride | 2006 |
Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Haloperidol; Humans; Lewy Body Disease; Neostriatum; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride | 2007 |
In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.
Topics: Animals; Autoradiography; Biotransformation; Brain; Central Nervous System; Chemical Phenomena; Chemistry, Physical; Cyclohexanols; Haloperidol; Iodine Radioisotopes; Isotope Labeling; Male; Narcotic Antagonists; Nootropic Agents; Pentazocine; Piperazines; Piperidines; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Tissue Distribution | 2007 |
Transdermal delivery enhancement of haloperidol from gel formulations by 1,8-cineole.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Cyclohexanols; Drug Carriers; Eucalyptol; Excipients; Gels; Haloperidol; Humans; Hypromellose Derivatives; In Vitro Techniques; Male; Methylcellulose; Mice; Monoterpenes; Permeability; Polyethylene Glycols; Rabbits; Skin Absorption; Species Specificity; Thermodynamics | 2008 |
Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Inflammatory Agents; Antidepressive Agents; Benzazepines; Cyclohexanols; Dopamine Antagonists; Dose-Response Relationship, Drug; Estradiol; Haloperidol; Hindlimb Suspension; Male; Mice; Motor Activity; Progesterone; Receptors, Dopamine; Receptors, Serotonin; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sigma-1 Receptor; Sulpiride; Swimming; Venlafaxine Hydrochloride | 2008 |
Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bridged Bicyclo Compounds; CA3 Region, Hippocampal; Calcineurin; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Cyclohexanols; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Haloperidol; Levodopa; Mice; Mice, Inbred C57BL; Molecular Conformation; Motor Activity; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Neurotransmitter; Stereoisomerism | 2011 |
Solubility evaluation of different root canal sealing materials.
Topics: Aluminum Compounds; Calcium Compounds; Calcium Hydroxide; Chloroform; Composite Resins; Cyclohexanols; Drug Combinations; Epoxy Resins; Eucalyptol; Eucalyptus; Humans; Immersion; Materials Testing; Monoterpenes; Oxides; Root Canal Filling Materials; Silicates; Solubility; Solvents; Temperature; Time Factors; Zinc Oxide-Eugenol Cement | 2015 |
Dissolution of a mineral trioxide aggregate sealer in endodontic solvents compared to conventional sealers.
Topics: Aluminum Compounds; Analysis of Variance; Bismuth; Calcium Compounds; Calcium Hydroxide; Chloroform; Cyclohexanols; Drug Combinations; Epoxy Resins; Eucalyptol; Immersion; Materials Testing; Monoterpenes; Oxides; Reference Values; Reproducibility of Results; Root Canal Filling Materials; Salicylates; Silicates; Silver; Solubility; Solvents; Time Factors; Titanium; Ultrasonic Waves; Zinc Oxide-Eugenol Cement | 2016 |
Influence of solvents on the bond strength of resin sealer to intraradicular dentin after retreatment.
Topics: Analysis of Variance; Cyclohexanols; Dental Bonding; Dental Instruments; Dental Pulp Cavity; Dentin; Epoxy Resins; Eucalyptol; Gutta-Percha; Humans; Materials Testing; Microscopy, Electron, Scanning; Monoterpenes; Plant Oils; Reproducibility of Results; Retreatment; Root Canal Filling Materials; Root Canal Preparation; Solvents | 2017 |